Impact of the timing of capsule endoscopy in overt obscure gastrointestinal bleeding on yield and rebleeding rate - is sooner than 14 d advisable?

Table 6 Outcomes between ≤ 48 h and > 48 h groups and < 14 d and ≥ 14 d groups

Outcome	≤ 48 h	> 48 h	P1 (≤ 48 h vs > 48h)	< 14 d	≥ 14 d	P1 (< 14 d vs ≥ 14 d)
DY	32 (82.1)	60 (78.9)	0.69	62 (83.8)	30 (73.2)	0.17
TY	26 (66.7)	27 (35.5)	0.002	40 (54.1)	13 (31.7)	0.02
RR	6 (15.4)	31 (43)	0.004	18 (25)	19 (46.3)	0.008
Time to re-bleed, yr	1 yr, 11.8	1 yr, 1		1 yr, 15.6	1 yr, 21.9
	2 yr, 11.8	2 yr, 31.1		2 yr, 20.4	2 yr, 31.4
	3 yr, 18.5	3 yr, 42.6		3 yr, 26.8	3 yr, 46.9
	4 yr, 18.5	4 yr, 52		4 yr, 30.6	4 yr, 58.2
	5 yr, 60	5 yr, 59.7		5 yr, 38.3	5 yr, 64.2
Mortality	9 (23.1)	19 (25)	0.82	19 (25.7)	9 (22)	0.66

¹χ² test; P value of 0.05 indicating statistical significance. DY: Diagnostic yield; TY: Therapeutic yield; RR: Re-bleeding rate.